Healthy pregnancy hub

Amitriptyline

Last Update: 01 Jun 2026

Medication
Welcome to our fact sheet on amitriptyline during pregnancy and lactation. This information is based on available published literature. It should not take the place of medical care and advice from your healthcare provider.

The HEALTHY PREGNANCY HUB team is collaborating with MotherToBaby to share information on this topic. The original version is available here (June 2024).

Serene, our chatbot, can also answer your questions about medications during pregnancy.

Please note that this fact sheet is based on United States information and has been adapted for Canada, with a review by our Canadian experts. Minor differences may exist between the two countries. Always consult your healthcare professional for information tailored to your situation.

1. What is amitriptyline?

Amitriptyline is a medication that used to treat depression, pain, tinnitus (noise or ringing sounds in the ear), irritable bowel syndrome, neuropathy (nerve damage) due to diabetes mellitus, and migraine headaches. Amitriptyline belongs to a group of medications called tricyclic antidepressants. It is sold under different brand names, including Amaril®, Amitrid®, Elavil®, Endep®, and Vanatrip®.  

Sometimes when people find out they are pregnant, they think about changing how they take their medication, or stopping their medication altogether. However, it is important to talk with your healthcare providers before making any changes to how you take your medication. Your healthcare providers can talk with you about the benefits of treating your condition and the risks of untreated illness during pregnancy. 

Pregnancy might affect how the body breaks down this medication. Some people might need to have their medication doses changed as pregnancy progresses. 

Some people might have a return of their symptoms (relapse) if they stop taking this medication during pregnancy. If you plan to stop this medication, your healthcare provider might suggest that you slowly lower the dose instead of stopping all at once. Stopping this medication suddenly can cause some people to have withdrawal symptoms. It is not known if or how withdrawal might affect a pregnancy. 

Note: Other medications are usually preferred to relieve pain or treat depression during pregnancy. However, amitriptyline may be considered as an option for some pregnant individuals if other medications have not been effective. 

2. What does research say about the safety during pregnancy?

I take amitriptyline. Can it make it harder for me to get pregnant?

Studies have not been done to see if amitriptyline could make it harder to get pregnant. 

Does taking amitriptyline increase the chance of miscarriage?

Miscarriage is common and can occur in any pregnancy for many different reasons. It is not known if amitriptyline can increase the chance of miscarriage. On another hand, untreated depression might increase the chance of miscarriage. More information on depression can be found in our fact sheet here. 

Does taking amitriptyline increase the chance of birth defects?

Out of all babies born each year, about 3 out of 100 (3%) will have a birth defect. It is called the background risk. We look at research studies to try to understand if an exposure, like amitriptyline, might increase the chance of birth defects in a pregnancy. A small number of human studies have not found a higher chance for birth defects with doses of amitriptyline used for treatment of depression. 

Does taking amitriptyline in pregnancy increase the chance of other pregnancy-related problems?

Studies have not been done to see if amitriptyline can increase the chance of other pregnancy-related problems such as preterm delivery (birth before week 37) or low birth weight (weighing less than 5 pounds, 8 ounces [2500 grams] at birth).  

One report found a small increase in the chance of preeclampsia (high blood pressure and problems with organs, such as the kidneys) when amitriptyline was used in the second and third trimester of pregnancy. 

Research has also shown that when depression is left untreated during pregnancy, there could be an increased chance of pregnancy complications. This makes it hard to know if the medication, untreated depression, or other factors are increasing the chance of these problems. 

I need to take amitriptyline throughout my entire pregnancy. Will it cause withdrawal symptoms in my baby after birth?

The use of some tricyclic antidepressants during pregnancy can cause temporary symptoms in newborns soon after birth. These symptoms are sometimes referred to as withdrawal. Symptoms seen during the first month of life included colic, low oxygen levels, breathing problems, and irritability. If a baby develops these symptoms, they usually go away in a few days without any long-term health effects. 

There is one case report of an infant who had temporary withdrawal symptoms after exposure to amitriptyline throughout pregnancy. Not all babies exposed to amitriptyline will have these symptoms. It is important that your healthcare providers know you are taking amitriptyline so that if symptoms occur your baby can get the care that is best for them. 

Does taking amitriptyline in pregnancy affect future behavior or learning for the child?

One study looking at 29 children exposed to amitriptyline during pregnancy did not find any behavioral or learning problems. 

3. Lactating while taking amitriptyline

Amitriptyline gets into breast milk in small amounts. There are several reports of amitriptyline being used while lactating. No side effects have been reported in most nursing infants. 

There was one report of a person who was taking 10 mg of amitriptyline per day while lactating. The breastfeeding baby (15 days old) was reported to be very sleepy. When the medication was stopped, the infant’s sleepiness resolved. 

The benefits of using amitriptyline might outweigh the risks of an untreated medical condition. If you suspect the baby has any symptoms (being too sleepy), contact the child’s healthcare provider. Your healthcare providers can talk with you about using amitriptyline and what treatment is best for you. Be sure to talk to your healthcare provider about all your breast/chest feeding questions. 

4. What about fathers and sperm donors?

If a male takes amitriptyline, could it affect fertility or increase the chance of birth defects?

Some studies report amitriptyline lowered sex drive and caused sexual dysfunction in male, which can affect fertility (ability to get a person pregnant). These problems can also be side effects of untreated depression. Studies have not been done to see if amitriptyline could increase the chance of birth defects. In general, exposures that fathers and sperm donors have are unlikely to increase risks to a pregnancy. For more information, please see the MotherToBaby fact sheet Paternal Exposures here.

Key points

  • Amitriptyline (Elavil®) is a medication from the tricyclic antidepressant family used to treat, among other things, depression, chronic pain, and migraines. 
  • It is not known whether this medication can affect fertility, the risk of miscarriage, or other problems during pregnancy. 
  • Studies show that taking amitriptyline during pregnancy, at recommended doses, does not appear to increase the risk of birth defects in the baby. 
  • Some babies exposed during pregnancy may have temporary symptoms after birth. 
  • A small amount of the medication passes into human milk, but no harmful effects have been observed in most nursed babies. 
  • In males, amitriptyline can sometimes reduce sexual desire or cause sexual difficulties, which could make conception more difficult. 
  • Always talk with a healthcare professional before changing or stopping any medication. 

References

Please click here for references.

URL copied!

Disclaimer

HEALTHY PREGNANCY HUB provides a source of information validated by health professionals; however, this information is provided for informational purposes only and should not replace professional advice. Medical standards and practices evolve as new data becomes available, so it is imperative to consult your doctor or a qualified health professional for any questions or concerns regarding your health without delay or omission. It is the responsibility of your treating physician or any other health professional, based on their independent experience and knowledge of the patient, to determine the best way to evaluate and treat you.

HEALTHY PREGNANCY HUB does not specifically recommend or endorse any test, practitioner, treatment, product, or opinion mentioned on our platform. HEALTHY PREGNANCY HUB also does not replace the individual patient assessment based on the examination by the healthcare provider of each patient and the consideration of laboratory data and other patient-specific factors.

The use of the information available on our site is at your own risk. No person involved in the creation, production, promotion, or marketing of HEALTHY PREGNANCY HUB guarantees or represents, expressly or implicitly, anything regarding the information available on the platform, which is provided “as it is”. All warranties are expressly excluded and disclaimed, including but not limited to implied warranties of merchantability or fitness for a particular purpose, as well as any warranties arising by law or otherwise in law or from trade or usage. Any statements or representations made by any other person or entity are void.

While consulting symptoms or other medical information on our platform may guide your discussions with your healthcare professional, this information should not be used to make a medical diagnosis or determine treatment. Before making changes to your supplement or medication regimen, please discuss with your medical team or contact 811 (Canada) to ensure the relevance of these changes to your individual situation.

Credits
MotherToBaby
Organization of Teratology Information Specialists (OTIS)
View source
Sherif Eltonsy
University of Manitoba
Brigitte Martin
Centre Hospitalier Universitaire Sainte-Justine
Vanina Tchuente
Centre hospitalier universitaire Sainte-Justine
Émy Roberge
Centre hospitalier universitaire Sainte-Justine
Evelyne Rey
CHU Sainte-Justine

Associated Fact Sheets

You want to know more about this topis? Discover our associated Fact Sheets!

Associated Resources

Want to know more? Discover our other contents associated to the topic.

Our interactive tools

Ask your questions and receive help from our personalized AI.

Try it now!

Explore our reading assistance tool.

Test them out today!

Partners

Your pregnancy during COVID-19
uOttawa
University of Calgary
University of British Columbia
University of Saskatchewan
University of Manitoba
University of Alberta
Unité de soutien SSA
UDEM
Stratos
SOGC
RQRM
QTNPR
QPC
PWHR
Public Health Agency of Canada
PregMed France
SPOR
MPrint
Mitacs
Médicaments Grossesse
McGill
Médicament Québec
FRQ
Perinatal Network
CIHR
IQVIA
iPOP
Institut national de santé publique du Québec
INRS
Innovative Medicines Canada
IN-uTERO
Immerscience
Groww
Enrich
Design Develop Discover
CUSM
CIHR
CHU Sainte-Justine
Centre of Excellence on Partnership with Patients and the Public
CAN-AIM
Canadian Pharmacogenomics Network for Drug Safetry
CAMCCO
CAMCCO-L
C4T
BORN Ontario
Black Physicians of Canada
BC Children's Hospital
Alberta Health Services
MICYRN
UQAT
Dalhousie University